George B. Thornton
Chief Tech/Sci/R&D Officer bei CASSAVA SCIENCES, INC.
Profil
George B.
Thornton is currently the Senior Vice President-Technology at Cassava Sciences, Inc. and a Trustee at Torrey Pines Institute For Molecular Studies, Inc. He previously worked as the Managing Director at Apovia, Inc., Director at Orphagen Pharmaceuticals, Vice President-PreClinical Development at gMed., Inc., and Chief Technology Officer at Apovia AG.
Thornton received his undergraduate degree from Abilene Christian University and his doctorate from the University of Texas Graduate School of Biomedical Sciences.
Aktive Positionen von George B. Thornton
| Unternehmen | Position | Beginn |
|---|---|---|
| CASSAVA SCIENCES, INC. | Chief Tech/Sci/R&D Officer | - |
Torrey Pines Institute For Molecular Studies, Inc.
 Torrey Pines Institute For Molecular Studies, Inc. Miscellaneous Commercial ServicesCommercial Services Torrey Pines Institute for Molecular Studies, Inc. operates as a non-profit research center. The firm conducts research in various fields including: multiple sclerosis, cancer, heart disease, types I and II diabetes, macular degeneration, pain management, alzheimer's disease, inflammatory disorders, AIDS and other infectious diseases, regenerative medicine, obesity, transplant rejection, muscle wasting syndrome, rheumatoid arthritis and new methods for drug discovery. The company was founded by Dr. Richard A. Houghten in 1988 and is headquartered in Port St. Lucie, FL. | Director/Board Member | - |
Ehemalige bekannte Positionen von George B. Thornton
| Unternehmen | Position | Ende |
|---|---|---|
Orphagen Pharmaceuticals
 Orphagen Pharmaceuticals Pharmaceuticals: MajorHealth Technology Orphagen Pharmaceuticals develops and manufactures drugs. The company was founded by Scott Thacher in 2001 and is headquartered in San Diego, CA. | Director/Board Member | - |
gMed., Inc.
 gMed., Inc. BiotechnologyHealth Technology gMed is engaged in providing physicians with information solutions to “Care Better” for their patients and practice. The company provides Digital Charting solutions for Gastroenterology and Cardiology designed to eliminate paper, increase revenues, decrease costs and enhance patient care at the medical office, ambulatory surgery center and hosptial. gMED was founded in 1997 and is located in Weston, FL. | Corporate Officer/Principal | - |
| Apovia AG | Chief Tech/Sci/R&D Officer | - |
| Apovia, Inc. | Corporate Officer/Principal | - |
Ausbildung von George B. Thornton
| Abilene Christian University | Undergraduate Degree |
| University of Texas Graduate School of Biomedical Sciences | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| CASSAVA SCIENCES, INC. | Health Technology |
| Private Unternehmen | 5 |
|---|---|
gMed., Inc.
gMed., Inc. BiotechnologyHealth Technology gMed is engaged in providing physicians with information solutions to “Care Better” for their patients and practice. The company provides Digital Charting solutions for Gastroenterology and Cardiology designed to eliminate paper, increase revenues, decrease costs and enhance patient care at the medical office, ambulatory surgery center and hosptial. gMED was founded in 1997 and is located in Weston, FL. | Health Technology |
| Apovia AG | |
| Apovia, Inc. | |
Orphagen Pharmaceuticals
Orphagen Pharmaceuticals Pharmaceuticals: MajorHealth Technology Orphagen Pharmaceuticals develops and manufactures drugs. The company was founded by Scott Thacher in 2001 and is headquartered in San Diego, CA. | Health Technology |
Torrey Pines Institute For Molecular Studies, Inc.
Torrey Pines Institute For Molecular Studies, Inc. Miscellaneous Commercial ServicesCommercial Services Torrey Pines Institute for Molecular Studies, Inc. operates as a non-profit research center. The firm conducts research in various fields including: multiple sclerosis, cancer, heart disease, types I and II diabetes, macular degeneration, pain management, alzheimer's disease, inflammatory disorders, AIDS and other infectious diseases, regenerative medicine, obesity, transplant rejection, muscle wasting syndrome, rheumatoid arthritis and new methods for drug discovery. The company was founded by Dr. Richard A. Houghten in 1988 and is headquartered in Port St. Lucie, FL. | Commercial Services |
